Carnegie Mellon University
Pittsburgh, Pennsylvania, United States
Sai Yerneni is a Moderna Global Postdoctoral Scholar in Kathryn Whitehead's laboratory at Carnegie Mellon University (CMU), where he is developing delivery systems for mRNA therapeutics. His future lab will focus on engineering biomaterials (lipid nanoparticles, microneedles, hydrogels etc.) and RNA medicine for applications in cancer, regenerative medicine, cardiovascular diseases, immune dysfunction and genetic disorders. Sai completed his PhD in Biomedical Engineering at CMU under the mentorship of Drs. Lee Weiss and Phil Campbell. His thesis, entitled 'Engineering Extracellular Vesicles for Health and Disease,' focused on developing bioengineering tools to study extracellular vesicle-mediated cell-to-cell communication and utilizing that knowledge to engineer bioinspired drug delivery systems. Sai’s PhD work garnered awards from the International Society for Extracellular Vesicles, American Society for Bone and Mineral Research, Society for Biomaterials and the International Society for Biofabrication. As a postdoctoral fellow, Sai received the CAS Future Leader Award from the American Chemical Society and the Postdoctoral Recognition Award from the Biomedical Engineering Society. Prior to his training at CMU, Sai earned a Bachelor's degree in Biotechnology at Anna University, India where he received the Achiever’s Award for exceptional performance.
Disclosure information not submitted.
Enabling mRNA Therapy for Fragile X Syndrome
Thursday, October 24, 2024
4:45 PM – 5:00 PM EST